ELECTROCARDIOGRAPHIC (ECG) ABNORMALITIES IN DIABETIC PATIENTS PRESENTING WITH CHEST PAIN: CORRELATION WITH GLYCEMIC CONTROL AND CARDIAC ENZYMES
DOI:
https://doi.org/10.71000/j7njfs81Keywords:
Chest pain, Cardiovascular Diseases, Diabetes Mellitus, Electrocardiography, Glycated Hemoglobin A, Myocardial Ischemia, Troponin IAbstract
Background: Diabetes mellitus is strongly linked with accelerated atherosclerosis, subclinical myocardial injury, and a high burden of cardiovascular complications. Individuals with Type 2 Diabetes Mellitus frequently present with atypical or silent ischemic symptoms, making timely diagnosis challenging and increasing the risk of delayed treatment. Electrocardiography and cardiac biomarkers offer valuable insight for early detection of myocardial stress, particularly in patients with poor metabolic control. Determining the relationship between glycemic status, ECG abnormalities, and troponin elevation is therefore essential for effective cardiovascular risk assessment in this high-risk population.
Objective: This study aimed to determine the association between glycemic control (HbA1c), ECG abnormalities, and elevated troponin I levels in diabetic patients presenting with chest discomfort, and to evaluate whether poor glycemic regulation predicts myocardial ischemia or injury identifiable through ECG or cardiac biomarkers.
Methods: A six-month cross-sectional analytical study was conducted in the Cardiology Department of CMARTH, enrolling 255 adults (≥18 years) with confirmed Type 2 Diabetes Mellitus presenting with chest pain. Patients with CKD stage ≥3, structural heart disease, non-diabetic status, or incomplete records were excluded. Data collection included 12-lead ECG interpreted independently by two physicians, HbA1c measurement categorized according to ADA criteria, and serum troponin I testing. Statistical analysis using SPSS version 23 involved descriptive statistics, Pearson correlation, and cross-tabulation to evaluate associations between glycemic status, ECG abnormalities, and troponin levels.
Results: The mean age of participants was 63.03 ± 11.24 years, with female predominance (69.01%). ST depression was present in 26.7%, ST elevation in 22%, T-wave inversion in 24.3%, arrhythmias in 11.8%, and non-specific changes in 15.3%. Most patients (73.72%) had uncontrolled diabetes (HbA1c ≥ 6.5%). Elevated troponin I levels showed a significant positive correlation with poor glycemic control, indicating increased myocardial injury in metabolically uncontrolled individuals.
Conclusion: Poor glycemic control was significantly associated with both elevated troponin I and ECG abnormalities in diabetic patients with chest pain, underscoring the need for routine cardiac screening and strict metabolic management to reduce cardiovascular complications.
References
Abdissa, S. G., Deressa, W., & Shah, A. J. (2020). Incidence of heart failure among diabetic patients with ischemic heart disease: a cohort study. BMC Cardiovasc Disord, 20(1), 181.
Achila, O. O., Fessahye, N., Mengistu, S. T., Habtemikael, N. T., Werke, W. Y., Zemichael, F. T., . . . Garoy, E. Y. (2022). A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea. Sci Rep, 12(1), 5567
Alexescu, T.-G., Nechita, A., Alexander, P., Perné, M.-G., Milaciu, M.-V., Ciulei, G., . . . Orășan, O.-H. (2025). Electrocardiographic Changes in Patients with Type 2 Diabetes Mellitus—A Meta-Analysis. Journal of Mind and Medical Sciences, 12(1), 14.
Alshaya, O. A., Korayem, G. B., Alghwainm, M., Alyami, W., Alotaibi, A., Alyami, M. S., & Almohammed, O. A. (2024). The prevalence of cardiovascular diseases, chronic kidney disease, and obesity in patients with type 2 diabetes mellitus and the description of concurrent treatments: A two-center retrospective cross-sectional study in Saudi Arabia. Saudi Pharm J, 32(5), 102054.
Arya, T., Kumar, R., Aziz, T., Alam, M. S., & Kujur, A. (2024). Exploring electrocardiographic alterations and the prolongation of QT interval in patients with diabetes mellitus. J Family Med Prim Care, 13(11), 5033-5039.
Islam, K., Islam, R., Nguyen, I., Malik, H., Pirzadah, H., Shrestha, B., . . . Kaye, A. D. (2025). Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments. Advances in Therapy, 42(6), 2659-2678.
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., . . . Liu, Y. (2023). Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal transduction and targeted therapy, 8(1), 152.
Siam, N. H., Snigdha, N. N., Tabasumma, N., & Parvin, I. (2024). Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies. Rev Cardiovasc Med, 25(12), 436.
Lin KD, Chang LH, Wu YR, Hsu WH, Kuo CH, Tsai JR, et al. Association of depression and parasympathetic activation with glycemic control in type 2 diabetes mellitus. J Diabetes Complications. 2022;36(8):108264.
Braffett BH, El Ghormli L, Martin C, White NH, Hirsch IB, Bantle A, et al. Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. Cardiovasc Diabetol. 2025;24(1):334.
Gotta V, Bachmann S, Pfister M, Donner B. Characterizing Associations of QTc Interval with Nocturnal Glycemic Control in Children with Type 1 Diabetes. J Clin Pharmacol. 2023;63(10):1147-55.
Cheng W, Chen H, Tian L, Ma Z, Cui X. A dataset on 24-h electrocardiograph, sleep and metabolic function of male type 2 diabetes mellitus. Data Brief. 2023;49:109421.
Pop-Busui R, Rosin SP, Butera NM, Krause-Steinrauf H, Abou Assi H, Garg RK, et al. Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort. Diabetes Care. 2025;48(11):1960-70.
Wan H, Zhou P, Fu W, Wu X, Yu Z, Shao C, et al. Efficacy and safety of Tongmai Jiangtang Capsule in the treatment of type 2 diabetes mellitus complicated with coronary heart disease with syndrome of damp - heat obstructing collaterals. Phytomedicine. 2025;147:157234.
Türe M, Akın A, Unal E, Kan A, Savaş S. Electrocardiographic data of children with type 1 diabetes mellitus. Cardiol Young. 2022;32(1):106-10.
Arya T, Kumar R, Aziz T, Alam MS, Kujur A. Exploring electrocardiographic alterations and the prolongation of QT interval in patients with diabetes mellitus. J Family Med Prim Care. 2024;13(11):5033-9.
Gupta K, Hirsch JR, Kalsi J, Patel V, Gad MM, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2023;25(1):31-41.
Heusser K, Tank J, Diedrich A, Fischer A, Heise T, Jordan J. Limited evidence for sympathetic neural overactivation in older patients with type 2 diabetes mellitus. Front Neurosci. 2022;16:1107752.
Dubourg J, Fouqueray P, Quinslot D, Grouin JM, Kaku K. Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial. Diabetes Obes Metab. 2022;24(4):609-19.
Tricò D, Sacchetta L, Rebelos E, Cimbalo N, Chiriacò M, Moriconi D, et al. Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications. Diabetologia. 2025;68(2):444-59.
Mohsin M, Zeyad H, Khalid H, Gapizov A, Bibi R, Kamani YG, et al. The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic Health. Cureus. 2023;15(9):e45881.
Bezen D, Türkmenoğlu Y, İrdem A. Ventricular depolarization and repolarization variability in children with type 1 diabetes mellitus. Pediatr Int. 2022;64(1):e15290.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ali Mehran, Qasim Tariq, Muhammad Ali, Muntaha Farooq, Eman Ahmed, Kiran Shehzadi, Mirza Muhammad Maroof Baig, Fatima Ashraf, Anas Jahangir (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.





